Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Purchase Of The Medicinal Product Trastuzumab Deruxtecan Under The Drug Program B.9.Fm "Treatment Of Patients With Breast Cancer"

UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU Poland has Released a tender for Purchase Of The Medicinal Product Trastuzumab Deruxtecan Under The Drug Program B.9.Fm "Treatment Of Patients With Breast Cancer" in Healthcare and Medicine. The tender was released on Nov 20, 2024.

Country - Poland

Summary - Purchase Of The Medicinal Product Trastuzumab Deruxtecan Under The Drug Program B.9.Fm "Treatment Of Patients With Breast Cancer"

Deadline - login to view

GT reference number - 97935376

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - Poland

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 97935376

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Purchase Of The Medicinal Product Trastuzumab Deruxtecan Under The Drug Program B.9.Fm "Treatment Of Patients With Breast Cancer"local title:: Zakup produktu leczniczego Trastuzumab deruxtecan w ramach Programu Lekowego Program B.9.FM " Leczenie chorych na raka piersi"Contract Type: : Supply

Gt Ref Id - 97935376

Deadline - Nov 28, 2024

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database